HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Sjöland Selected Research

Plasminogen Activators (Plasminogen Activator)

3/2000Atherosclerosis progression in LDL receptor-deficient and apolipoprotein E-deficient mice is independent of genetic alterations in plasminogen activator inhibitor-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Sjöland Research Topics

Disease

3Angina Pectoris
05/2001 - 04/2000
2Coronary Artery Disease (Coronary Atherosclerosis)
05/2001 - 06/2000
2Chest Pain (Chest Pains)
04/2001 - 01/2000
2Diabetes Mellitus
11/2000 - 06/2000
1Heart Arrest (Cardiac Arrest)
01/2008
1Myocardial Ischemia (Ischemic Heart Diseases)
04/2001
1Dyspnea (Shortness of Breath)
04/2001
1Disease Progression
03/2000
1Atherosclerosis
03/2000
1Hypertension (High Blood Pressure)
01/2000

Drug/Important Bio-Agent (IBA)

1ApolipoproteinsIBA
03/2000
1CholesterolIBA
03/2000
1FibrinIBA
03/2000
1PlasminogenIBA
03/2000
1Plasminogen Activators (Plasminogen Activator)IBA
03/2000
1LDL Receptors (LDL Receptor)IBA
03/2000
1Plasminogen InactivatorsIBA
03/2000
1Plasminogen Activator Inhibitor 1IBA
03/2000

Therapy/Procedure

8Coronary Artery Bypass (Coronary Artery Bypass Surgery)
05/2001 - 01/2000
1Cardiopulmonary Resuscitation (CPR)
01/2008